20 articles
Discover how persistent low-grade inflammation drives the aging process and learn strategies to combat this silent threat to longevity.
Master the molecular architecture of complement dysregulation in aging — from regulatory protein biochemistry to cutting-edge therapeutic targets — and understand how precision interventions can restore balance without dismantling immunity.
Go beyond the basics to explore how complement pathways, regulatory failures, and senescent cells interact to drive the chronic inflammation that accelerates aging at the molecular level.
A mechanistic deep-dive into cutting-edge anti-inflammaging interventions — from senolytic pharmacology and precision cytokine targeting to partial reprogramming strategies that aim to restore youthful immune homeostasis.
Senescent T cells fuel psoriasis, eczema, and rosacea through toxic secretions. New therapies may finally break the cycle.
Go beyond inflammaging basics to understand how aging reshapes immune cell populations, triggers the SASP, and locks the body into a state of chronic low-grade inflammation at the molecular level.
New research reveals how tissue fibroblasts orchestrate age-related inflammation, creating exhausted T cells that increase vulnerability to disease.
Two-year study shows aggressive treatment of axial spondyloarthritis reduces arterial plaque buildup by 73% when low disease activity is achieved.
New research reveals how IL-2 signaling generates special B cells that produce anti-inflammatory compounds, potentially slowing aging processes.
New research reveals how IL-1β and TGF-β cytokines work together to fuel joint inflammation and damage in rheumatoid arthritis patients.
A murine arthritis study finds rapamycin suppresses neuropeptide Y, linking cellular senescence to joint inflammation via SASP cytokines.
Scientists reveal how macrophages use mitochondria to clear dead cells while controlling immune responses, offering insights for healthier aging.
Scientists identify key cellular pathways driving lupus, revealing promising new therapeutic targets beyond current treatments.
New research reveals how necroptosis activates immune pathways, offering targets for inflammatory bowel disease treatment.
New targeted therapies and biomarker-driven approaches are revolutionizing RA management, potentially improving healthspan for millions.
Researchers reveal the immune mechanisms behind uveitis, a leading cause of preventable blindness, opening doors to targeted therapies.
Cancer immunotherapy drugs may enhance the body's natural healing processes by boosting regenerative immune responses.
Stanford researchers used modified immune proteins to enhance neurogenesis and cognitive function in aged mouse brains.
Scientists discover a direct pathway connecting skin and joint inflammation, revealing new targets for treating autoimmune conditions.
New research reveals how fat tissue activates T cells, potentially explaining the link between obesity and inflammatory joint disease.
